A clinical trial to study the pain relief effect of two local anesthetic drugs ropivacaine and bupivacaine given to block the nerves located in abdominal wall after caesarean section.

To Compare the efficacy of Ropivacaine versus Bupivacaine during Surgical transversus Abdominis plane block for post-operative analgesia after Caesarean Section

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/015979

Enrollment

100

Registered

2018-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: Ropivacaine: Ropivacaine will be used to administer the surgical transversus abdominis plane block. Control Intervention1: Bupivacaine: Bupivacaine will be used to administer Surgical T

Eligibility

Inclusion criteria

Inclusion criteria: all patients who require caesarean delivery

Exclusion criteria

Exclusion criteria: Patient with ASA III or above Any allergy to used drug Local infection at the site of block Patients requiring vertical abdominal incision and upper segment caesarean section Patients requiring general anesthesia Height of patient less than 150 cms and more than 180 cms (as these patients will require a different dosage of spinal anaesthesia) Patients with thrombocytopenia.

Design outcomes

Primary

Measure	Time frame
Outcome Name: Post operative pain relief. To be assessed by Visual Analogue score [VAS]Timepoint: Time Point: One hourly assessment for 8 hours	—

Secondary

Measure	Time frame
Outcome Name: Side effects of the drugsTimepoint: Time Points: Every hour assessment in post operative period for 24 hours.	—

Countries

India

Contacts

Public ContactDr Aniket Kakade

Bharati Vidyapeeth [Deemed to be University] Medical College, Pune

aniket1kakade@gmail.com02045555555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026